60 results
Keyword Ipilimumab Remove keyword
Responsible body
PDCO Remove PDCO filter
-
List item
Paediatric Committee (PDCO): 23-26 January 2018
European Medicines Agency, London, UK, from 23/01/2018 to 26/01/2018, Last updated: 10/04/2018 -
List item
Paediatric Committee (PDCO): 12-14 August 2015
European Medicines Agency, London, UK, from 12/08/2015 to 14/08/2015, Last updated: 19/02/2013 -
List item
Paediatric Committee (PDCO): 21-24 February 2017
European Medicines Agency, London, UK, from 21/02/2017 to 24/02/2017, Last updated: 03/07/2014 -
List item
Paediatric Committee (PDCO): 13-16 December 2016
European Medicines Agency, London, UK, from 13/12/2016 to 16/12/2016, Last updated: 30/06/2014 -
List item
Paediatric Committee (PDCO): 17-19 July 2013
European Medicines Agency, London, UK, from 17/07/2013 to 19/07/2013, Last updated: 21/12/2010 -
List item
Paediatric Committee (PDCO): 20-23 February 2018
European Medicines Agency, London, UK, from 20/02/2018 to 23/02/2018, Last updated: 18/07/2014 -
List item
Paediatric Committee (PDCO): 8-11 November 2016
European Medicines Agency, London, UK, from 08/11/2016 to 11/11/2016, Last updated: 30/06/2014 -
List item
Paediatric Committee (PDCO): 16-18 July 2014
European Medicines Agency, London, UK, from 16/07/2014 to 18/07/2014, Last updated: 10/12/2010 -
List item
Paediatric Committee (PDCO): 17-19 June 2015
European Medicines Agency, London, UK, from 17/06/2015 to 19/06/2015, Last updated: 20/07/2015 -
List item
Paediatric Committee (PDCO): 14-16 May 2012
European Medicines Agency, London, UK, from 14/05/2012 to 16/05/2012, Last updated: 25/08/2011activities EMA/PDCO/307494/2012 Page 3/6 Ipilimumab, from Bristol-Myers Squibb … -
List item
Paediatric Committee (PDCO): 18-20 April 2011
European Medicines Agency, London, UK, from 18/04/2011 to 20/04/2011, Last updated: 11/06/2010cardiovascular diseases; Ipilimumab, from Bristol-Myers Squibb … -
List item
Press release: Meeting highlights from the Paediatric Committee: 17 - 19 September 2008
PDCO, Last updated: 28/09/2008area of haematology; Ipilimumab, from Bristol-Myers Squibb …